18F-FDG and 18F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma.
Autor: | Kim, Mai, Higuchi, Tetsuya, Nakajima, Takahito, Andriana, Putri, Hirasawa, Hiromi, Tokue, Azusa, Kurihara, Jun, Yokoo, Satoshi, Tsushima, Yoshito |
---|---|
Předmět: |
AMINO acids
COMPUTED tomography DEOXY sugars LYMPH nodes METASTASIS MOUTH tumors MULTIVARIATE analysis RADIOPHARMACEUTICALS RESEARCH evaluation RISK assessment SQUAMOUS cell carcinoma STATISTICS SURVIVAL analysis (Biometry) POSITRON emission tomography SYMPTOMS PREDICTIVE tests PROPORTIONAL hazards models ODDS ratio PROGNOSIS |
Zdroj: | Oral Radiology; Sep2019, Vol. 35 Issue 3, p308-314, 7p |
Abstrakt: | Objectives: L-3-[18F]-Fluoro-α-methyl tyrosine (FAMT), an amino acid positron emission tomography (PET) tracer, complements [18F]-fluorodeoxyglucose (FDG) in the diagnosis of malignancies. We compared the predictive ability of FAMT PET versus FDG PET regarding metastatic oral squamous cell carcinoma (OSCC) outcomes for distant metastasis, including lymph node metastasis, and identified the relevant metabolic parameters for each. Methods: We enrolled 160 patients with OSCC who underwent PET/computed tomography using FDG and FAMT before treatment. Outcomes were assessed using clinicopathological characteristics such as the standardized uptake value (SUV |
Databáze: | Complementary Index |
Externí odkaz: |